Myotonic Dystrophies and Non Dystrophic Myotonies

  • PIP4 (MEX-NM-301): An Open-label, non-Comparative Study to Evaluate the Steady-State Pharmacokinetics, Safety, and Efficacy of Mexiletine in Adolescents and Children with Myotonic Disorders
  • PIP7 (MEX-NM-303): Open-label Extension Study to Evaluate the Long-term Safety and Efficacy of Mexiletine in Paediatric Patients with Myotonic Disorders Who Have Completed MEX-NM-301 Study

 

Acronym

PIP4 (MEX-NM-301)

PIP7 (MEX-NM-303)
Intervention Namuscla™ (Mexiletine) Namuscla™ (Mexiletine)
Principal Investigator Arnaud Isapof Arnaud Isapof
Sponsor Lupin Lupin
Study status Ongoing Ongoing
Recruitment status Ongoing Ongoing
Population Child Child